Subchronic and chronic PCP treatment produces temporally distinct deficits in attentional set shifting and prepulse inhibition in rats (Q42166759)

17 October 2017

Subchronic and chronic PCP treatment produces temporally distinct deficits in attentional set shifting and prepulse inhibition in rats (English)

1 reference

17 October 2017

1 reference

Alice Egerton

1

1 reference

17 October 2017

Lee Reid

2

1 reference

17 October 2017

Sandie McGregor

3

1 reference

17 October 2017

Susan M Cochran

4

1 reference

17 October 2017

Brian J Morris

5

1 reference

17 October 2017

Judith A Pratt

6

1 reference

17 October 2017

23 April 2008

1 reference

17 October 2017

1 reference

17 October 2017

198

1 reference

17 October 2017

1

1 reference

17 October 2017

37-49

1 reference

https://scigraph.springernature.com/pub.10.1007/s00213-008-1071-5

17 October 2017

0 references

cites work

Phencyclidine-induced psychosis

1 reference

https://api.crossref.org/works/10.1007%2FS00213-008-1071-5

Hypofrontality in neuroleptic-naive patients and in patients with chronic schizophrenia. Assessment with xenon 133 single-photon emission computed tomography and the Tower of London

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-008-1071-5

Gating and habituation of the startle reflex in schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-008-1071-5

National Institute of Mental Health longitudinal study of chronic schizophrenia. Prognosis and predictors of outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-008-1071-5

Association of ketamine-induced psychosis with focal activation of the prefrontal cortex in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-008-1071-5

Frontostriatal disorder of cerebral metabolism in never-medicated schizophrenics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-008-1071-5

Positron emission tomography studies of abnormal glucose metabolism in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-008-1071-5

The brain metabolic patterns of clozapine- and fluphenazine-treated patients with schizophrenia during a continuous performance task.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-008-1071-5

Animal models for the negative symptoms of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-008-1071-5

Recent advances in the phencyclidine model of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-008-1071-5

Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-008-1071-5

Selective abnormalities of prefrontal serotonergic receptors in schizophrenia. A postmortem study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-008-1071-5

Neural circuit regulation of prepulse inhibition of startle in the rat: current knowledge and future challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-008-1071-5

Limbic System Abnormalities Identified in Schizophrenia Using Positron Emission Tomography With Fluorodeoxyglucose and Neocortical Alterations With Deficit Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-008-1071-5

Negative symptoms and hypofrontality in chronic schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-008-1071-5

Auditory hallucinations and the temporal cortical response to speech in schizophrenia: a functional magnetic resonance imaging study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-008-1071-5

Evidence of dysfunction of a prefrontal-limbic network in schizophrenia: a magnetic resonance imaging and regional cerebral blood flow study of discordant monozygotic twins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-008-1071-5

Information-processing deficits and thought disorder in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-008-1071-5

Sensitization to amphetamine, but not PCP, impairs attentional set shifting: reversal by a D1 receptor agonist injected into the medial prefrontal cortex

21 January 2018

1 reference

12 December 2020

Brain activation during cognitive stimulation with the Wisconsin Card Sorting Test--a functional MRI study on healthy volunteers and schizophrenics.

1 reference

12 December 2020

Automation of the social interaction test by a video-tracking system: behavioural effects of repeated phencyclidine treatment.

1 reference

12 December 2020

Effects of neuroleptic medications on the cognition of patients with schizophrenia: a review of recent studies

1 reference

12 December 2020

Extra-dimensional versus intra-dimensional set shifting performance following frontal lobe excisions, temporal lobe excisions or amygdalo-hippocampectomy in man

1 reference

12 December 2020

Corticolimbic dopamine neurotransmission is temporally dissociated from the cognitive and locomotor effects of phencyclidine.

1 reference

12 December 2020

Effects of dopamine agonists and antagonists on PCP-induced stereotyped behaviour and social isolation in the rat social interaction test

1 reference

12 December 2020

Negative schizophrenic symptomatology and the PCP (phencyclidine) model of schizophrenia.

1 reference

12 December 2020

Phencyclidine in the social interaction test: an animal model of schizophrenia with face and predictive validity

1 reference

12 December 2020

Performance of schizophrenic patients on putative neuropsychological tests of frontal lobe function.

1 reference

12 December 2020

Neuropsychological evidence for frontostriatal dysfunction in schizophrenia

1 reference

12 December 2020

Effects of the 5-HT(7) receptor antagonist SB-258741 in animal models for schizophrenia

1 reference

12 December 2020

Effects of novel antipsychotics with mixed D(2) antagonist/5-HT(1A) agonist properties on PCP-induced social interaction deficits in the rat.

1 reference

12 December 2020

Dextro-amphetamine diminishes negative symptoms in schizophrenia.

1 reference

12 December 2020

Acute and chronic behavioral interactions between phencyclidine (PCP) and amphetamine: evidence for a dopaminergic role in some PCP-induced behaviors

1 reference

12 December 2020

The atypical antipsychotic drug clozapine enhances chronic PCP-induced regulation of prefrontal cortex 5-HT2A receptors

1 reference

12 December 2020

Beyond the K-hole: a 3-year longitudinal investigation of the cognitive and subjective effects of ketamine in recreational users who have substantially reduced their use of the drug

1 reference

12 December 2020

NMDA receptor function and human cognition: the effects of ketamine in healthy volunteers.

1 reference

12 December 2020

Persistent elevations in dopamine and its metabolites in the nucleus accumbens after mild subchronic stress in rats with ibotenic acid lesions of the medial prefrontal cortex.

1 reference

12 December 2020

Recovery of neuropsychological functions during reduction in use of phencyclidine

1 reference

12 December 2020

Auditory hallucinations inhibit exogenous activation of auditory association cortex.

1 reference

12 December 2020

Effects of diazepam, citalopram, methadone and naloxone on PCP-induced stereotyped behaviour and social isolation in the rat social interaction test.

1 reference

12 December 2020

Symptom correlates of prepulse inhibition deficits in male schizophrenic patients

1 reference

12 December 2020

Proton magnetic resonance spectroscopy (H-MRS) studies of schizophrenia.

1 reference

12 December 2020

Chronic phencyclidine induces behavioral sensitization and apoptotic cell death in the olfactory and piriform cortex.

1 reference

12 December 2020

Single photon emission computed tomography in phencyclidine and related drug abuse

1 reference

12 December 2020

On the nature of Wisconsin Card Sorting Test performance in schizophrenia

1 reference

12 December 2020

The current status of the dopamine hypothesis of schizophrenia

1 reference

12 December 2020

(+) MK-801 and phencyclidine induced neurotoxicity do not cause enduring behaviours resembling the positive and negative symptoms of schizophrenia in the rat.

1 reference

12 December 2020

Effects of the 5-HT(6) receptor antagonist, SB-271046, in animal models for schizophrenia

1 reference

12 December 2020

PCP-induced alterations in cerebral glucose utilization in rat brain: blockade by metaphit, a PCP-receptor-acylating agent

1 reference

12 December 2020

Selective 6OHDA-induced destruction of mesolimbic dopamine neurons: abolition of psychostimulant-induced locomotor activity in rats

1 reference

12 December 2020

Effects of continuous D-amphetamine and phencyclidine administration on social behaviour, stereotyped behaviour, and locomotor activity in rats

1 reference

12 December 2020

Patterns of cortical activity in schizophrenia

1 reference

12 December 2020

A deficit profile of executive, memory, and motor functions in schizophrenia.

1 reference

12 December 2020

The regulation of subcortical dopamine systems by the prefrontal cortex: interactions of central dopamine systems and the pathogenesis of schizophrenia.

1 reference

12 December 2020

Partial improvement in negative schizophrenic symptoms after amphetamine

1 reference

12 December 2020

Subchronic phencyclidine administration reduces mesoprefrontal dopamine utilization and impairs prefrontal cortical-dependent cognition in the rat.

1 reference

12 December 2020

Phencyclidine-induced stereotyped behaviour and social isolation in rats: a possible animal model of schizophrenia.

1 reference

12 December 2020

The behavioral and neurochemical effects of phencyclidine in humans and animals: some implications for modeling psychosis

1 reference

12 December 2020

Glutamatergic neurotransmission modulation and the mechanisms of antipsychotic atypicality

1 reference

12 December 2020

Executive dysfunction in first-episode schizophrenia and relationship to duration of untreated psychosis: the West London Study.

1 reference

12 December 2020

Enduring cognitive deficits and cortical dopamine dysfunction in monkeys after long-term administration of phencyclidine.

1 reference

12 December 2020

Induction of metabolic hypofunction and neurochemical deficits after chronic intermittent exposure to phencyclidine: differential modulation by antipsychotic drugs

1 reference

12 December 2020

Distinct effects of d-amphetamine and phencyclidine on the social behaviour of rats.

1 reference

12 December 2020

Schizophrenia and anteroventral thalamic nucleus: selective decrease of parvalbumin-immunoreactive thalamocortical projection neurons.

1 reference

12 December 2020

Symptoms, cognitive functioning, and adaptive skills in geriatric patients with lifelong schizophrenia: a comparison across treatment sites

1 reference

12 December 2020

Parvalbumin-immunoreactive neurons are reduced in the prefrontal cortex of schizophrenics.

1 reference

12 December 2020

PCP: from pharmacology to modelling schizophrenia

1 reference

12 December 2020

A meta-analysis and critical review of the effects of conventional neuroleptic treatment on cognition in schizophrenia: opening a closed book

1 reference

12 December 2020

The role of endogenous sensitization in the pathophysiology of schizophrenia: implications from recent brain imaging studies

1 reference

12 December 2020

Effect of novel antipsychotic drugs on phencyclidine-induced stereotyped behaviour and social isolation in the rat social interaction test.

1 reference

12 December 2020

N-acetylaspartate and N-Acetylaspartylglutamate deficits in superior temporal cortex in schizophrenia and bipolar disorder: a postmortem study

1 reference

12 December 2020

Acute delta9-tetrahydrocannabinol-induced deficits in reversal learning: neural correlates of affective inflexibility

1 reference

12 December 2020

Sensorimotor gating and thought disturbance measured in close temporal proximity in schizophrenic patients

1 reference

12 December 2020

Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review

1 reference

12 December 2020

Decreased frontal activation in schizophrenics during stimulation with the Continuous Performance Test - a functional magnetic resonance imaging study

1 reference

12 December 2020

Delayed regional metabolic actions of phencyclidine

1 reference

12 December 2020

Chronic phencyclidine administration induces schizophrenia-like changes in N-acetylaspartate and N-acetylaspartylglutamate in rat brain

1 reference

12 December 2020

Alterations in local cerebral glucose utilization induced by phencyclidine.

1 reference

12 December 2020

Reduced prefrontal activity predicts exaggerated striatal dopaminergic function in schizophrenia

1 reference

12 December 2020

Social interaction deficits caused by chronic phencyclidine administration are reversed by oxytocin

1 reference

12 December 2020

Dramatic limbic and cortical effects mediated by high affinity PCP receptors.

1 reference

12 December 2020

Prestimulus effects on human startle reflex in normals and schizophrenics

1 reference

12 December 2020

PDE10A inhibition reverses subchronic PCP-induced deficits in attentional set-shifting in rats

1 reference

12 December 2020

Metabolic hyperfrontality and psychopathology in the ketamine model of psychosis using positron emission tomography (PET) and [18F]fluorodeoxyglucose (FDG).

1 reference

12 December 2020

The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia

1 reference

12 December 2020

Cognitive function in schizophrenia--do neuroleptics make a difference?

1 reference

12 December 2020

A test of the predictive validity of animal models of schizophrenia based on phencyclidine and D-amphetamine

1 reference

12 December 2020

Glucose metabolic rate in normals and schizophrenics during the Continuous Performance Test assessed by positron emission tomography

1 reference

12 December 2020

Cerebral metabolic activity correlates of subsyndromes in chronic schizophrenia.

1 reference

12 December 2020

Study of a new schizophrenomimetic drug; sernyl.

1 reference

12 December 2020

Positive and negative symptom response to clozapine in schizophrenic patients with and without the deficit syndrome.

1 reference

12 December 2020

Rule shift under long-term PCP challenge in rats

1 reference

12 December 2020

Medial frontal cortex mediates perceptual attentional set shifting in the rat.

1 reference

12 December 2020

Acute and delayed effects of phencyclidine upon mRNA levels of markers of glutamatergic and GABAergic neurotransmitter function in the rat brain

1 reference

12 December 2020

Impairment in perceptual attentional set-shifting following PCP administration: a rodent model of set-shifting deficits in schizophrenia

1 reference

12 December 2020

Subchronic phencyclidine administration alters central vasopressin receptor binding and social interaction in the rat

1 reference

12 December 2020

Subchronic phencyclidine treatment impairs performance of C57BL/6 mice in the attentional set-shifting task

1 reference

12 December 2020

Sensitization to amphetamine, but not phencyclidine, disrupts prepulse inhibition and latent inhibition

1 reference

12 December 2020

Cortical regulation of subcortical dopamine systems and its possible relevance to schizophrenia

1 reference

12 December 2020

Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs

1 reference

12 December 2020

SSR181507, a putative atypical antipsychotic with dopamine D2 antagonist and 5-HT1A agonist activities: improvement of social interaction deficits induced by phencyclidine in rats

1 reference

12 December 2020

1 reference

12 December 2020

Comparison of set-shifting ability in patients with chronic schizophrenia and frontal lobe damage.

1 reference

12 December 2020

Studies of cognitive change in patients with schizophrenia following novel antipsychotic treatment

1 reference

12 December 2020

Withdrawal from chronic phencyclidine treatment induces long-lasting depression in brain reward function

1 reference

12 December 2020

Subchronic phencyclidine administration increases mesolimbic dopaminergic system responsivity and augments stress- and psychostimulant-induced hyperlocomotion.

1 reference

12 December 2020

Hypofrontality in unmedicated schizophrenia patients studied with PET during performance of a serial verbal learning task

1 reference

12 December 2020

Clozapine effects on glucose metabolic rate in striatum and frontal cortex

1 reference

12 December 2020

10.1007/S00213-008-1071-5

Identifiers

DOI

1 reference

Dimensions Publication ID

17 October 2017

0 references

1 reference